Cargando…
Splenomegaly during oxaliplatin-based chemotherapy: impact on blood parameters and anti-neoplastic treatment
BACKGROUND: Oxaliplatin induces splenomegaly, which can cause blood sequestration and relevant cytopenia, leading to further dose reductions and schedule modifications of chemotherapy. Here, we aimed to explore the changes of spleen volume induced by oxaliplatin as well as its impact on blood parame...
Autores principales: | Ji, Ruoyu, Huang, Guanghua, Xu, Jing, Yu, Xiaoduo, Zhou, Aiping, Du, Chunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560872/ https://www.ncbi.nlm.nih.gov/pubmed/36249886 http://dx.doi.org/10.21037/tcr-22-83 |
Ejemplares similares
-
Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020) -
Correction: Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020) -
Oxaliplatin-induced haematological toxicity and splenomegaly in mice
por: Lees, Justin G., et al.
Publicado: (2020) -
A Case of Liver Fibrosis with Splenomegaly after Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer
por: Kang, Gu Hyum, et al.
Publicado: (2013) -
Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer
por: Kang, Jeonghyun, et al.
Publicado: (2018)